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Recent studies have revealed that the use of probiotics is an alternative to control marine aeromonas. However, few probiotics
are available against Aeromonas hydrophila infections in eels. In the present study, a potential antagonistic strain G1 against the
eel-pathogenic A. hydrophila was isolated from sediment underlying brackish water. Its extracellular products with antibacterial
activities were shown to be stable under wide range of pH, temperature, and proteinase K. It was initially identiﬁed as Bacillus
amyloliquefaciens using API identiﬁcation kits and conﬁrmed to be B. amyloliquefaciens strain (GenBank accession number
DQ422953)byphylogeneticanalysis.Inaddition,itwasshowntobesafeformammalians,hadawideanti-A.hydrophilaspectrum,
and exhibited signiﬁcant eﬀects on inhibiting the growth of the eel-pathogenic A. hydrophila both in vitro and in vivo.T ot h eb e s t
ofourknowledge,thisistheﬁrstreportonapromisingantagonisticBacillusamyloliquefaciensstrainfrombrackishwatersediment
against eel-pathogenic A. hydrophila.
1.Introduction
Eels are important warm water ﬁsh species cultured in
several European countries including Italy, Spain, Germany,
Denmark, and the Netherlands, as well as in Japan, Taiwan,
Malaysia, and China [1]. Among the cultured eels, Anguilla
anguilla (L.) is one of the most important commercial
ﬁsh species, especially in the brackish Comacchio lagoons
of the northern Adriatic Sea [2]. For decades, outbreaks
of infectious diseases caused by Aeromonas hydrophila are
considered to be a major economic problem to the aquacul-
ture and quality of Anguilla anguilla (L.), leading to severe
losses in the production and marketing of A. anguilla (L.)
[3, 4]. At present, aeromonas can be partially controlled by
ﬁsh farmers with crude application of antibiotics such as
terramycin and ﬂorfenicol. However, antibiotic treatment is
cost-prohibitive to farmers in many undeveloped and devel-
opingcountries,andantibioticusemaybedetrimentaltothe
environment and human health, involving the development
and transfer of antibiotic resistance to other aquatic bacteria,
ﬁsh pathogens, human pathogens, and the accumulation of
antibiotic residuals in the products [5]. Thus, besides the
alternative control strategies such as improved husbandry
and water quality, better nutrition, lower stocking densities,
the use of beneﬁcial microorganisms is also widely expected
to become an alternative method for the prevention and
control of aeromonas.
Microbial antagonism is a common phenomenon in
nature [6] and plays a major role in reducing or eliminating
theincidenceofopportunisticpathogensinthegastrointesti-
nal tract of aquatic animals [7]. Recently, the application
of Bacillus sp. as a probiotic species for controlling aquatic
pathogens shows promise [8]. For example, Sugita et al.
isolated a Bacillus strain that was antagonistic to 63% of
the isolates from ﬁsh intestine [9]. Sun et al. obtained two
dominant gut Bacillus strains with antagonistic activity that
could improve growth performance and immune responses
of grouper Epinephelus coioides [10]. However, no informa-
tion is available about B. amyloliquefaciens as a biocontrol
agent for aquatic pathogens.
In this study, we isolated a B. amyloliquefaciens strain G1
antagonistic to the eel-pathogenic A. hydrophila, determined
its taxonomic position, observed the physicochemical prop-
erties of its extracellular products, and assayed its in vitro2 Evidence-Based Complementary and Alternative Medicine
and in vivo growth inhibition eﬀects on A. hydrophila,
and its antagonistic spectrum and pathogenicity. The data
could establish its potential as an environmentally friendly
probiotic for eel aquaculture.
2.MaterialsandMethods
2.1. Sample Collection and Isolation of Marine Bacteria.
Brackish water sediment samples were collected from perch
andwhiteshrimpfarmslocatedatQingpuDistrict,Shanghai
China. The samples were kept in a refrigerator until use. One
gramofthesedimentwassuspendedin100mLofautoclaved
ﬁltered brackish water, heated for 10min at 80◦Ct od e s t r o y
vegetative bacteria and fungi to facilitate isolation of bacilli
with spores that survived the heat pretreatment. Sediment
samples were then incubated in a shaker incubator (Thermo
Forma Co. Ltd., USA) at 30◦C with shaking at 200rpm
for 30min. Mixtures were allowed to settle, serial dilutions
up to 10−4 were prepared using sterile distilled water and
agitated with a vortex (Hushi Laboratory Equipment Co.
Ltd., Shanghai) at 200rpm. Isolation of bacteria from this
mixture was done with serial dilution technique on brackish
water nutrient agar (NA) (Sinopharm Chemical Reagent
Co. Ltd., Shanghai) medium. Puriﬁcation of bacteria was
done using repeated streaking and single colony culture at
30◦C. Bacterial isolates were subcultured and transferred to
brackish water NA slants. Until further use, the slants were
kept at 4◦C as described by Das et al. [11].
2.2. Screening of Antagonistic Bacteria
2.2.1. Indicator Bacterium. A. hydrophila strain ZN1, the
pathogenofsepticemiainEuropeaneelAnguilla Anguilla (L.)
[12], was obtained from Fujian Institute of Aquatic Product
in Freshwater.
2.2.2.AntibacterialActivityAssay. Theantibacterialactivities
of all the bacterial isolates were examined against the eel-
pathogenic A. hydrophila strain ZN1 by the paper disc
method [13]. Brieﬂy, a culture of A. hydrophila was indepen-
dently spread on brackish water NA plates, then the 5mm
sterile paper discs containing the bacterial isolate with a cell
density of 106 cfu/disc were placed on the brackish water
NA plates. Control plates consisted of A. hydrophila only.
Zones of inhibition around the paper discs were observed
a n dr e c o r d e do nA. hydrophila lawn culture plates after two
days of incubation at 30◦C.
2.3. Phenotypic Characterization and Identiﬁcation. The iso-
late was grown on brackish water NA plates (Sinopharm
Chemical Reagent Co., Ltd.) at 30◦C for 24h, and then the
bacterial suspension was used to inoculate the 50 CHB/E
API strip (Bio-Merieux, SA) following the manufacturer’s
instruction. The strip was incubated at 30◦Ca n do b s e r v e d
after 48h for checking against the API identiﬁcation index
and database.
2.4. Molecular Identiﬁcation
2.4.1. DNA Extract, PCR, and Sequencing. The Genomic
DNA was extracted from a pure culture of the isolate using
a genomic DNA extraction kit following instructions of
the manufacturer (Shanghai Sangon Biological Engineering
T e c h n o l o g y&S e r v i c e sC o . ,L t d . ) .T h e1 6 Sr R N Ag e n e
fragments (ca. 1.5kb) were ampliﬁed by PCR using a pair
of universal bacterial 16S rRNA gene primers (27f): 5 -
AGAGTTTGATCCTGGCTCAG-3  and (1492r): 5 -TAC-
GGCTACCTTGTTACGACTT-3 . The PCR was carried out
according to Nduhiu et al. [14]. Brieﬂy, 1μL of the DNA
extract was ampliﬁed in a 25μL reaction mix containing
16.75μLsterilizeddistilledwater,2.5μLdeoxyribonucleoside
triphosphate (dNTP 10mM), 2.5μL 10x buﬀer, 1μLM g C l 2
(50mM), 0.5μL of each primer (10mM), and 0.25μL( 1U )
ExTaq DNA polymerase. Ampliﬁcation was done using 35
cycles of denaturation at 95◦C for 1min, annealing at 60◦C
for 1min, and extension at 72◦Cf o r1 . 5 m i nf o l l o w e db y
aﬁ n a le x t e n s i o n7 2 ◦C for 7min using a PCR minicycler
(Eppendorf Ltd., Germany). The PCR product was elec-
trophoresed on 1% agarose gel and visualized via ultraviolet
transillumination. Sequencing was performed by a ﬂuores-
cent labeled dideoxynucleotide termination method (with
BigDyeterminator)onABI3730automatedDNASequencer.
2.4.2. Phylogenetic Analysis. The partial 16S rRNA sequence
was assembled using MegAlign, Editseq, and Seqman soft-
warewithaMacintoshcomputer.Searchesweredoneagainst
the National Centre for Biotechnology Information (NCBI)
database using the Basic Local Alignment Search Tool
(BLAST) program. The phylogenetic tree based on the 16S
rRNA gene sequence of the isolate was constructed using the
neighbor-joining method.
2.5. Physicochemical Analysis of Extracellular Products
2.5.1. Preparation of the Extracellular Products. The isolate
was incubated in 400mL of brackish water nutrient broth
(NB) (Sinopharm Chemical Reagent Co. Ltd., Shanghai)
medium at 30◦C with shaking at 200rpm until the cell
density reached 109 cfu/mL. Then the cultured medium was
centrifuged at 8000rpm at 4◦C for 20min, the supernatant
containing the antagonistic substance was extracted, and the
extracellular products (ECPs) were obtained as described by
Bordoloi et al. [15]. Brieﬂy, the supernatant was extracted
twice with equal volumes of ethyl acetate (1:1). The crude
extract was dried over sodium sulfate and then evaporated
under vacuum.
2.5.2.PHStabilityAssay. TheinﬂuenceofpHonthestability
of ECPs was measured in the pH range of 5.0 to 9.0 as
described by Lee et al. [16]. Brieﬂy, the 10mg of ECPs was
added to 50μLo f5 0m Mc i tri ca c i db u ﬀer (pH 5), potassium
phosphate buﬀer (pH 6–8), and carbohydrate buﬀer (pH
9) (Sinopharm Chemical Reagent Co. Ltd., Shanghai), then
each mixture was applied to A. hydrophila strain ZN1Evidence-Based Complementary and Alternative Medicine 3
lawn cell plates. Zones of inhibition were recorded on A.
hydrophila lawn culture plates.
2.5.3. Thermal Stability Assay. The analysis on the thermal
stability of ECPs was examined as described by Lee et al.
[16]. Brieﬂy, the 10mg of ECPs was treated independently at
20, 40, 60, 80, and 100◦C for 30min. Then each treatment
sample was applied to A. hydrophila strain ZN1 lawn cell
plates. Zones of inhibition were recorded on A. hydrophila
lawn culture plates.
2.5.4. Enzyme Stability Assay. The 10mg of ECPs was digest-
ed with 15μL of proteinase K (974U/mL) (Shanghai Sangon
Biological Engineering Technology and Services Co. Ltd.) at
30◦C for 2h. Then the processed sample was applied to A.
hydrophila strain ZN1 lawn cell plates. Zones of inhibition
were recorded on A. hydrophila lawn culture plates.
2.6.InVitroPathogenGrowthInhibitionAssay. Theassaywas
carried out in twelve 250mL glass ﬂask supplied with 98mL
of brackish water NB medium, and each treatment consisted
of three ﬂasks. In each ﬂask, 1mL of the isolate’s suspen-
sion with a ﬁnal cell density of 103 cfu/mL, 104 cfu/mL,
105 cfu/mL, and 1mL of the A. hydrophila suspension with a
ﬁnal cell density of 103 cfu/mL were independently inoculat-
edin98mLofbrackishwaterNBmedium,thenthemixtures
were incubated at 30◦C with shaking at 200rpm. The control
group consisted of A. hydrophila strain only. Cell growth of
A.hydrophilawasmeasuredusingbrackishwaterRSmedium
(Beijing Land Bridge Technology Co. Ltd.) at 24h intervals.
2.7. Antagonistic Spectrum Assay. Eight pathogenic strains of
A.hydrophila(ATCC7966,X1,S1,T3,R402L,RK1119,706C,
and 40142G) were obtained fromNational Collection Centre
for Aquatic Pathogens, China. The antagonistic spectrum of
the isolate was checked against the eight pathogenic A.
hydrophila strains by the paper disc method [13]. The antag-
onisticactivityagainstA.hydrophilastrainZN1wasservedas
the control. Zones of inhibition were observed and recorded
on A. hydrophila lawn culture plates after two days of incu-
bation at 30◦C.
2.8. Virulence Assay. H e m o l y t i ca c t i v i t ya s s a yw a sc a r r i e d
out with brackish water rabbit blood agar (RBA) plates
(Sinopharm Chemical Reagent Co., Ltd.) at 30◦Cf o r2d a y s .
Virulence was further assayed in mice. Brieﬂy, four-week-
old female BALB/c mice, weighing 20g each, were obtained
from Laboratory Animal Centre of Second Military Medical
University, Shanghai. Mice were lightly anesthetized with
Halothane (Sinopharm Chemical Reagent Co., Ltd.) in a
glass desiccator and challenged with the isolate’s suspension
prepared as mentioned above. The isolate’s suspension was
orally administered at the ﬁnal cell density of 105,1 0 6,1 0 7,
108,a n d1 0 9 cfu/g through a micropipette ﬁtted with a ﬁne
micropipette tip and thin ﬂexible tube. The control mice
were orally administered with the autoclaved brackish water
NB medium. Ten mice were tested in each dilution. The mice
were housed in cages at 20–25◦C, fed with the pellet feed and
puriﬁed water. Mice were examined daily and any signs of
disease and mortality were recorded up to 14 days. The 50%
lethal dose (LD50) was determined according to Mittal et al.
[17].
2.9. In Vivo Protection Test. Ninety Anguilla anguilla (L.),
weighing 90–100g each, were allowed to acclimatize for 7
days and were randomly placed in three 200L tanks (10
ﬁsh per tank, three tank per group) for the three treatments
(the control, low cell density, and high cell density groups)
described below. The tanks used recycled brackish water
that was kept at 28◦C throughout the experiment. The
isolate’s suspension was prepared as mentioned above and
its cell densities were determined. Under sterile conditions,
the isolate was manually incorporated into commercial dry
pellets at rates of 3 × 107 and 3 × 109 cfu/g in feed for low
and high cell densities of the isolate diets, respectively. Fish
fed only commercial dry pellets served as a control. Fish
were fed approximately 1% of body weight once a day. Two
weeks after feeding, all the ﬁsh were bath-challenged with
skin scariﬁcation through exposure to A. hydrophila strain
ZN1 with a ﬁnal cell density of 109 cfu/mL as recommended
by Schadich and Cole [18]. Brieﬂy, all the ﬁsh were skin
scariﬁed, the skin scariﬁed ﬁsh in the low cell density and
high cell density groups were exposed to the suspension
of A. hydrophila strain ZN1 overnight, while the skin
scariﬁed ﬁsh were exposed individually to brackish water
only. After the bacterial exposure, the ﬁsh were returned to
their living containers. Dead ﬁsh were immediately removed
for pathogen isolation as described by Bucke [19], and
mortalities were recorded each day for 14 days following the
immersion challenge.
2.10. Statistical Analysis. Data were presented as the mean ±
standard deviation (SD) for the indicated number of inde-
pendently performed experiments. P<0.05 was considered
statistically signiﬁcant using one-way analysis of variance.
3. Results
3.1. Isolation of Marine Antagonistic Strains. A total of 45
bacteriawereisolatedfromthebrackishwatersedimentsam-
ples.Onlyoneisolate,namedG1,wasfoundtoexhibitstrong
antagonistic activity to the eel-pathogenic A. hydrophila
strain ZN1, displaying inhibition zones of 15mm (data
not shown). According to Lategan et al. [20], zones of
inhibition >12mm against A. hydrophila were considered as
susceptibility to the isolates. Thus, isolate G1 was chosen for
further study.
3.2. Characterization and Identiﬁcation. The API identiﬁca-
tion kits identiﬁed isolate G1 as Bacillus amyloliquefaciens
(data not shown), and it showed an identity of 94% with
the type strain ATCC23350 in phenotypic characterization.
Isolate G1 and the type strain ATCC23350 were found
both positive for glycerin, L-Arabinose, D-Ribose, D-Xylose,
D-Galactose, D-Glukose, D-Fructose, D-Mannose, inosi-
tol, D-Mannitol, D-Sorbitol, Methyl-αD-Glucopyranoside,4 Evidence-Based Complementary and Alternative Medicine
Bacillus velezensis strain An4-2 [AB244441]
Bacillus licheniformis strain H3 [FJ713021]
Bacillus amyloliquefaciens strain TC5 [AB300808]
Bacillus amyloliquefaciens strain TC3 [AB300806]
Bacillus amyloliquefaciens strain GBSW11 [GU568203]
Bacillus vallismortis strain JY3A [GU205781]
Bacillus subtilis strain NEW2 [EU771079]
Bacillus subtilis strain QD517 [EF472261]
Bacillus amyloliquefaciens strain Ba-32732C [EU531505]
Bacillus subtilis strain TC-1 [EU489517]
Bacillus sp. AmS2 [EU864532]
Bacillus subtilis strain 261 [EF445123]
Bacillus amyloliquefaciens strain Ba-74501 [DQ422953]
Strain G1
Bacillus subtilis strain Pab02 [EU346662]
Bacillus velezensis strain BM-Y3 [FJ426275]
Bacillus amyloliquefaciens strain 19E2 [FJ705346]
Bacillus vallismortis strain ST47 [FJ386541]
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Figure 1: Phylogenetic tree constructed using neighbor-joining method.
amygdalin, arbutin, esculin, salicin, D-Cellobiose, D-Mal-
tose, D-Lactose, D-Melibiose, D-Saccharose, D-Trehalose,
D-Melezitose, D-Raﬃnose, amidon, glycogen, and gentio-
biose. However, there were some diﬀerences between isolate
G1 and the type strain ATCC23350. For example, in contrast
to the type strain ATCC23350, isolate G1 was unable to
ferment inulin.
The 1.5kb 16S rRNA sequence of isolate G1 was sub-
mitted to GenBank database with the accession number
HM245965. Similarities between the 16S rRNA sequence of
isolate G1 and those of B. amyloliquefaciens strains in
the GenBank database were 99.0%, which proved the ini-
tial identiﬁcation. The constructed phylogenetic tree using
neighbor-joining method further demonstrated that isolate
G1wascloselyrelatedtotheB.amyloliquefaciensstrain(Gen-
Bank accession number DQ422953) (Figure 1). The identiﬁ-
cation result from phylogenetic analysis was consistent with
that found through API identiﬁcation kits.
3.3. Physicochemical Properties of the Extracellular Products.
The ECPs were obtained from the supernatant (pH 8.5)
of isolate G1 with ethyl acetate. The ECPs could inhibit
the growth of the eel-pathogenic A. hydrophila, creating the
clear inhibition zone on the A. hydrophila lawn culture plate
(data not shown). The antagonistic activity of the ECPs was
retained over the wide pH range of 5.0 to 9.0 against A.
hydrophila strain ZN1, and it was also thermally stable at up
to 100◦C for 30min, both showing no signiﬁcant diﬀerence
between the inhibition zones (data not shown). In addition,
the antagonistic activity of the ECPs was still retained with
proteinase K treatment, forming a clear zone on the A.
hydrophila lawn culture plate (data not shown). The results
indicatedthattheantagonisticsubstanceintheECPswassta-
ble under wide range of pH, temperature, and proteinase K.
3.4. In Vitro Growth Inhibition Eﬀect. The in vitro eﬀect
of isolate G1 on the growth inhibition of A. hydrophila
strain ZN1 was shown in Figure 2. The cell density of A.
hydrophila was signiﬁcantly lower than that in the control
when isolate G1 was inoculated at the ﬁnal cell density of
103 to 105 cfu/mL, and the logarithms of the cell density of
A. hydrophila were, respectively, reduced by 32.65%, 47.28%,
and 59.49% after the incubation of 96h, compared with the
control group. The result indicated that isolate G1 could be
used for exclusion of A. hydrophila.
3.5. Antagonistic Activity against Aeromonas hydrophila
Strains. Theantagonisticactivityagainsttheeightpathogen-
ic A. hydrophila strains was shown in Figure 3. The result
indicated that isolate G1 had highly antagonistic activityEvidence-Based Complementary and Alternative Medicine 5
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Figure 2: Inhibitory eﬀect of srain G1 at the ﬁnal cell density of
103 cfu/mL (A), 104 cfu/mL (B), 105 cfu/mL (C), and 0cfu/mL (D)
on the growth of the eel-pathogenic A. hydrophila.
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Figure 3: Antagonistic spectrum of srain G1 against pathogenic A.
hydrophila strains.
against the other pathogenic A. hydrophila strains besides
A. hydrophila strain ZN1. The maximum zone of inhibition
(18.5mm) was recorded in strain S1, and followed by
strain X1 (18.25mm), strain R402L (17.75mm), strain ZN1
(15mm), strain T3 (14.75mm), strain RK1119 (13.25mm),
and strain 706C (12.25mm). According to Lategan et al.
[20], zones of inhibition >12mm against A. hydrophila were
considered as susceptibility to the isolate. Therefore, isolate
G1 had a wide antagonistic spectrum against pathogenic A.
hydrophila strains.
3.6. Safety. No hemolytic activity was detected with isolate
G1, with no zones of hemolysis being formed on the RBA
plates (data not shown). In addition, no acute mortality or
anyvisiblediseasesignswereobservedinthetestmicetreated
with 105 to 109 cfu/g of isolate G1’s suspension (data not
shown). It is concluded that the LD50 value of isolate G1 was
estimated to exceed 109 cfu/g according to Mittal et al. [17].
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Figure 4: Protective eﬀect of srain G1 on Anguilla anguilla (L.)
under the eel-pathogenic A. hydrophila challenge trial.
3.7. In Vivo Protective Eﬀect. The in vivo protective eﬀect of
isolate G1 on Anguilla anguilla (L.) under the eel-pathogenic
A. hydrophila challenge trial was shown in Figure 4.A f t e r
14 days following the immersion challenge, the cumulative
mortality was 69.24% lower in the high cell density group
than in the control group, and the cumulative mortality was
also 30.76% lower in the low cell density group than in the
control group. The death of all the test ﬁsh observed in the
challenge trials was caused by A. hydrophila, as determined
by bacterial isolation and API identiﬁcation kits (data not
shown). The result indicated the protective eﬀect of isolate
G1 against A. hydrophila infection in Anguilla anguilla (L.).
4. Discussion
Theuseofantagonisticbacteriaiswidelyexpectedtobecome
an alternative method for the prevention and control of
bacterial disease in ﬁsh. Numerous studies have shown that
bacteriacanproduceinhibitorysubstancesthathadtheeﬀect
of inhibiting the bacterial pathogens in aquaculture systems
[13]. The use of such bacteria to inhibit pathogens by release
of antimicrobial substances is now gaining importance in
the eel farming as a better and more eﬀective alternative
than administering antibiotics to manage the health of eels
[18]. The present study reported a promising antagonistic
B. amyloliquefaciens isolate G1 from the brackish water sed-
iment samples, which showed antagonistic property towards
the eel-pathogenic A. hydrophila and other pathogenic A.
hydrophila strains. Our data indicated that the isolate could
beasuitablecandidateprobioticforeelfarming:(1)asigniﬁ-
cantinvitroinhibitoryeﬀectonthegrowthofeel-pathogenic
A.hydrophila;(2)asigniﬁcantinvivoprotectiveeﬀectagainst
A. hydrophila infection in Anguilla anguilla (L.); (3) stability
of the antagonistic action of its extracellular products over a
wide range of pH, temperatures, and proteinase K.
In the present study, the extracellular products (ECPs) of
isolate G1 showed inhibitory activity on the eel-pathogenic6 Evidence-Based Complementary and Alternative Medicine
A. hydrophila strain ZN1 (data not shown), and the inhibi-
tory activity of the ECPs was not signiﬁcantly aﬀected under
wide range of pH, temperature, and proteinase K. Relevant
studies indicated that the antagonistic action responsible
for the inhibition of bacterial pathogens such as Erwinia
amylovora, Ralstonia solanacearum was due to diﬃcidin,
bacilysin, or a 29kDa fusion protein of the LCI gene [21,
22]. The production of antibiotic substance by isolate G1
might be one of these important inhibiting agents. To clarify
this, further characterization of the inhibitory component of
isolate G1 would be necessary. In addition, the inhibitory
activity of the ECPs of isolate G1 even after treatment
at high temperatures (data not shown) and proteinase K
(data not shown) suggested the stability of the antagonistic
component. Similar observations were also recorded by Hu
et al. [22], who reported that the antibacterial activity of
the active fractions of B. amyloliquefaciens isolate Bg-C31
was not aﬀected at 100◦C and proteinase K. The property
of thermal stability would be useful during industrial level
production.
ForapplicationofisolateG1asaprobioticduringroutine
hatchery operations and natural A. hydrophila infections, the
data on the eﬀect of inhibiting the growth of A. hydrophila
were essential. The present study indicated that isolate G1
could signiﬁcantly reduce the cell density of A. hydrophila
by 32.65%, 47.28%, and 59.49% after the inoculation at the
ﬁnalcelldensity of103 to 105 cfu/mL,respectively(Figure 2),
and produced a maximum inhibition zone with 18.5mm
on A. hydrophila lawn culture plates (Figure 3). In a related
study on the antibacterial activity of Bacillus sp., Bacillus
subtilis strain P73 and strain P72 only exhibited a maximum
inhibition zone with 14.5mm on A. hydrophila lawn culture
plates [23]. Therefore, isolate G1 might be considered as a
stronger antagonistic bacterium.
In order to be considered as a probiotic for application,
the candidate strain had to be evaluated for its pathogenicity
to a mammalian system and protective eﬀect [24]. The
present study showed that isolate G1 could not form any
hemolytic rings on the RBA plates (data not shown), and the
LD50 value to BALB/c mice exceeded 109 cfu/g. As described
by Cutting [25], the Bacillus strain was regarded as no infec-
tivityortoxicity whenitsoralLD50 v a l u et om i c ei sa b o v e4 . 7
× 108 cfu/g. Thus, isolate G1 was evaluated as a safe strain.
Supplementation of Saccharomyces cerevisiae has been used
to control Aeromonas hydrophila infection in Oreochromis
niloticus (L.) [26], but no relevant data are available about
antagonistic bacteria against A. hydrophila infection in eels.
The present study indicated that supplementation of isolate
G1 could signiﬁcantly reduce the cumulative mortality
of Anguilla anguilla (L.) challenged with A. hydrophila
(Figure 4), conﬁrming the protective eﬀect of isolate G1
against A. hydrophila infection in eels.
In conclusion, the unique characteristics of B. amyloliq-
uefaciens G 1 ,s u c ha st h ea n t i b a c t e r i a lp r o p e r t yt o w a r d sa
wide spectrum of pathogenic A. hydrophila strains, the sig-
nificant growth inhibition eﬀect on the eel-pathogenic A.
hydrophila, the protective eﬀect against A. hydrophila infec-
tion in Anguilla anguilla (L.), resistance of its extracellular
productstoawiderangeofpH,temperatures,andproteinase
K, and its safety to the mammalian system, supported this
strain as a promising probiotic for the biocontrol of A.
hydrophila infections in A. anguilla (L.).
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